RecruitingPhase 2NCT07405801
A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer
Sponsor: Hoffmann-La Roche
Aberdeen, SD · Mitchell, SD · Pierre, SD · +7 more sites